Angiogenesis
Research results from Jilin University update understanding of angiogenesis
Published in Women's Health Weekly, May 10th, 2007
A report, "Inhibitory effect of ginsenoside Rg3 combined with cyclophosphamide on growth and angiogenesis of ovarian cancer," is newly published data in Chinese Medical Journal. According to recent research published in the Chinese Medical Journal, "Ginsenoside Rg3, the main component isolated from ginseng, inhibits some kinds of tumor growth and angiogenesis. The combination of low dose chemotherapy and antiangiogenesis inhibitors suppresses growth of experimental tumours more effectively than conventional therapy."
"The effect of this combination on ovarian cancer remains to be evaluated. Therefore, we investigated the synergism of ginsenoside Rg3 and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer
Neither abortion nor miscarriage associated with breast cancer risk - Depression
Mailman School of Public Health study shows smoking common during pregnancy - Hormones
Dry Eyes Are More Than a Nuisance - Menopause
Hot flashes -- Studies explore the role of genes, obesity and alcohol - Obesity
A woman's age at first menstruation influences risk of obesity for her children - Aging
Women Expect to Care for Aging Parents but Seldom Prepare - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
